These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25146459)

  • 1. Current and emerging drugs for acute bacterial skin and skin structure infections: an update.
    Kollipara R; Downing C; Lee M; Guidry J; Curtis S; Tyring S
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):431-40. PubMed ID: 25146459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.
    Beresford E; Biek D; Jandourek A; Mawal Y; Riccobene T; Friedland HD
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):123-35. PubMed ID: 24494793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for complicated skin and skin-structure infections.
    Mendoza N; Tyring SK
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):509-20. PubMed ID: 20557269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing and antibiotic selection among hospitalized patients with purulent skin infections.
    Terp S; Krishnadasan A; Bowen W; Joo J; Furoy D; Chan J; Moran G; Talan D
    Clin Infect Dis; 2014 Apr; 58(8):e129-32. PubMed ID: 24457337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good.
    Corey GR; Stryjewski ME
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S469-76. PubMed ID: 21546623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: the challenge of outpatient therapy.
    Pate AJ; Terribilini RG; Ghobadi F; Azhir A; Barber A; Pearson JM; Kalantari H; Hassen GW
    Am J Emerg Med; 2014 Feb; 32(2):135-8. PubMed ID: 24238483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
    Krause KM; Barriere SL; Kitt MM; Benton BM
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):181-5. PubMed ID: 20846593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The problem of complicated skin and skin structure infections: the need for new agents.
    Moellering RC
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv3-8. PubMed ID: 21115452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Bassetti M; Baguneid M; Bouza E; Dryden M; Nathwani D; Wilcox M
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():3-18. PubMed ID: 24580738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
    Amara S; Adamson RT; Lew I; Huang X
    Curr Med Res Opin; 2013 Jul; 29(7):869-77. PubMed ID: 23659559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines.
    Moran GJ; Abrahamian FM; Lovecchio F; Talan DA
    J Emerg Med; 2013 Jun; 44(6):e397-412. PubMed ID: 23466022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
    Jorgenson MR; DePestel DD; Carver PL
    Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRSA new treatments on the horizon: current status.
    Wilcox MH
    Injury; 2011 Dec; 42 Suppl 5():S42-4. PubMed ID: 22196910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistant pathogen-associated skin and skin-structure infections: antibiotic options.
    Curcio D
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1019-36. PubMed ID: 20818946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handling a community-acquired methicillin-resistant Staphylococcus aureus outbreak: emerging data.
    Elston DM
    Cutis; 2008 Aug; 82(2 Suppl 2):13-7. PubMed ID: 18924546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.
    Casapao AM; Steed ME; Levine DP; Rybak MJ
    Expert Opin Pharmacother; 2012 Jun; 13(8):1177-86. PubMed ID: 22594846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ; Egan DJ; Pelletier AJ; Espinola JA; Hooper DC; Camargo CA
    Ann Emerg Med; 2008 Mar; 51(3):291-8. PubMed ID: 18222564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.